Fate Therapeutics (FATE) Asset Utilization Ratio (2016 - 2025)
Fate Therapeutics (FATE) has disclosed Asset Utilization Ratio for 13 consecutive years, with 0.02 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, Asset Utilization Ratio fell 31.15% year-over-year to 0.02, compared with a TTM value of 0.02 through Dec 2025, down 31.15%, and an annual FY2025 reading of 0.02, down 39.22% over the prior year.
- Asset Utilization Ratio was 0.02 for Q4 2025 at Fate Therapeutics, up from 0.02 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 0.2 in Q1 2023 and bottomed at 0.01 in Q1 2024.
- Average Asset Utilization Ratio over 5 years is 0.07, with a median of 0.05 recorded in 2021.
- The sharpest move saw Asset Utilization Ratio surged 188.89% in 2023, then tumbled 94.12% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.06 in 2021, then skyrocketed by 125.9% to 0.13 in 2022, then decreased by 8.58% to 0.12 in 2023, then tumbled by 75.92% to 0.03 in 2024, then crashed by 31.15% to 0.02 in 2025.
- Business Quant data shows Asset Utilization Ratio for FATE at 0.02 in Q4 2025, 0.02 in Q3 2025, and 0.02 in Q2 2025.